CAS 1184843-57-9

SAR-020106

Description:

SAR-020106, identified by its CAS number 1184843-57-9, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of drug development. While specific characteristics such as its molecular formula, structure, and physical properties may vary, compounds in this category typically exhibit properties relevant to their biological activity. SAR-020106 is often studied for its potential therapeutic effects, which may include interactions with specific biological targets or pathways. Its solubility, stability, and reactivity are critical factors that influence its efficacy and safety profile. Additionally, the compound may undergo various forms of testing to assess its pharmacokinetics and pharmacodynamics. As with many research chemicals, detailed information may be limited, and ongoing studies are essential to fully elucidate its characteristics and potential applications in medicine. Always refer to the latest scientific literature or databases for the most current and comprehensive information regarding specific compounds.

SAR-020106

CAS: 1184843-57-9

SAR-020106

Purity: ≥95%

Molecular weight: 382.85g/mol

Ref: 54-BUP02440

SAR-020106

CAS: 1184843-57-9

Ref: 7W-GW6888

SAR-020106

CAS: 1184843-57-9

SAR-020106 is a potent, ATP-competitive, and selective CHK1 inhibitor with an IC50 of 13.3 nmol/L on the isolated human enzyme.

Formula: C₁₉H₁₉ClN₆O

Purity: 97.78%

Color and Shape: Solid

Molecular weight: 382.85

Ref: TM-T21331

SAR-020106

CAS: 1184843-57-9

SAR-020106 is a small molecule inhibitor that binds to the cell factor, preventing it from binding to its target on cells. SAR-020106 has been shown to inhibit the growth of solid tumours in vitro and in vivo. The mechanism of action is not known, but may be due to inhibition of thymidylate synthesis or induction of apoptosis. SAR-020106 has minimal toxicity and a low potential for drug resistance, which makes it an attractive candidate for cancer therapy. It also appears to be a potential biomarker for anti-cancer drug discovery programs.
SAR-020106 exhibits pharmacokinetic properties that are suitable for oral administration.

Formula: C₁₉H₁₉ClN₆O

Purity: Min. 95%

Molecular weight: 382.85 g/mol

Ref: 3D-JXB84357